Cargando…
Low-Density Lipoprotein Receptor Is a Key Driver of Aggressiveness in Thyroid Tumor Cells
We previously described the role of low-density lipoprotein (LDL) in aggressiveness in papillary thyroid cancer (PTC). Moreover, the MAPK signaling pathway in the presence of BRAF V600E mutation is associated with more aggressive PTC. Although the link between MAPK cascade and LDL receptor (LDLR) ex...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10342163/ https://www.ncbi.nlm.nih.gov/pubmed/37446330 http://dx.doi.org/10.3390/ijms241311153 |
_version_ | 1785072436933296128 |
---|---|
author | Revilla, Giovanna Ruiz-Auladell, Lara Vallverdú, Núria Fucui Santamaría, Paula Moral, Antonio Pérez, José Ignacio Li, Changda Fuste, Victoria Lerma, Enrique Corcoy, Rosa Pitoia, Fabián Escolà-Gil, Joan Carles Mato, Eugènia |
author_facet | Revilla, Giovanna Ruiz-Auladell, Lara Vallverdú, Núria Fucui Santamaría, Paula Moral, Antonio Pérez, José Ignacio Li, Changda Fuste, Victoria Lerma, Enrique Corcoy, Rosa Pitoia, Fabián Escolà-Gil, Joan Carles Mato, Eugènia |
author_sort | Revilla, Giovanna |
collection | PubMed |
description | We previously described the role of low-density lipoprotein (LDL) in aggressiveness in papillary thyroid cancer (PTC). Moreover, the MAPK signaling pathway in the presence of BRAF V600E mutation is associated with more aggressive PTC. Although the link between MAPK cascade and LDL receptor (LDLR) expression has been previously described, it is unknown whether LDL can potentiate the adverse effects of PTC through it. We aimed to investigate whether the presence of LDL might accelerate the oncogenic processes through MAPK pathway in presence or absence of BRAF V600E in two thyroid cell lines: TPC1 and BCPAP (wild-type and BRAF V600E, respectively). LDLR, PI3K-AKT and RAS/RAF/MAPK (MEK)/ERK were analyzed via Western blot; cell proliferation was measured via MTT assay, cell migration was studied through wound-healing assay and LDL uptake was analyzed by fluorometric and confocal analysis. TPC1 demonstrated a time-specific downregulation of the LDLR, while BCPAP resulted in a receptor deregulation after LDL exposition. LDL uptake was increased in BCPAP over-time, as well as cell proliferation (20% higher) in comparison to TPC1. Both cell lines differed in migration pattern with a wound closure of 83.5 ± 9.7% after LDL coculture in TPC1, while a loss in the adhesion capacity was detected in BCPAP. The siRNA knockdown of LDLR in LDL-treated BCPAP cells resulted in a p-ERK expression downregulation and cell proliferation modulation, demonstrating a link between LDLR and MAPK pathway. The modulation of BRAF-V600E using vemurafenib-impaired LDLR expression decreased cellular proliferation. Our results suggest that LDLR regulation is cell line-specific, regulating the RAS/RAF/MAPK (MEK)/ERK pathway in the LDL-signaling cascade and where BRAF V600E can play a critical role. In conclusion, targeting LDLR and this downstream signaling cascade, could be a new therapeutic strategy for PTC with more aggressive behavior, especially in those harboring BRAF V600E. |
format | Online Article Text |
id | pubmed-10342163 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-103421632023-07-14 Low-Density Lipoprotein Receptor Is a Key Driver of Aggressiveness in Thyroid Tumor Cells Revilla, Giovanna Ruiz-Auladell, Lara Vallverdú, Núria Fucui Santamaría, Paula Moral, Antonio Pérez, José Ignacio Li, Changda Fuste, Victoria Lerma, Enrique Corcoy, Rosa Pitoia, Fabián Escolà-Gil, Joan Carles Mato, Eugènia Int J Mol Sci Article We previously described the role of low-density lipoprotein (LDL) in aggressiveness in papillary thyroid cancer (PTC). Moreover, the MAPK signaling pathway in the presence of BRAF V600E mutation is associated with more aggressive PTC. Although the link between MAPK cascade and LDL receptor (LDLR) expression has been previously described, it is unknown whether LDL can potentiate the adverse effects of PTC through it. We aimed to investigate whether the presence of LDL might accelerate the oncogenic processes through MAPK pathway in presence or absence of BRAF V600E in two thyroid cell lines: TPC1 and BCPAP (wild-type and BRAF V600E, respectively). LDLR, PI3K-AKT and RAS/RAF/MAPK (MEK)/ERK were analyzed via Western blot; cell proliferation was measured via MTT assay, cell migration was studied through wound-healing assay and LDL uptake was analyzed by fluorometric and confocal analysis. TPC1 demonstrated a time-specific downregulation of the LDLR, while BCPAP resulted in a receptor deregulation after LDL exposition. LDL uptake was increased in BCPAP over-time, as well as cell proliferation (20% higher) in comparison to TPC1. Both cell lines differed in migration pattern with a wound closure of 83.5 ± 9.7% after LDL coculture in TPC1, while a loss in the adhesion capacity was detected in BCPAP. The siRNA knockdown of LDLR in LDL-treated BCPAP cells resulted in a p-ERK expression downregulation and cell proliferation modulation, demonstrating a link between LDLR and MAPK pathway. The modulation of BRAF-V600E using vemurafenib-impaired LDLR expression decreased cellular proliferation. Our results suggest that LDLR regulation is cell line-specific, regulating the RAS/RAF/MAPK (MEK)/ERK pathway in the LDL-signaling cascade and where BRAF V600E can play a critical role. In conclusion, targeting LDLR and this downstream signaling cascade, could be a new therapeutic strategy for PTC with more aggressive behavior, especially in those harboring BRAF V600E. MDPI 2023-07-06 /pmc/articles/PMC10342163/ /pubmed/37446330 http://dx.doi.org/10.3390/ijms241311153 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Revilla, Giovanna Ruiz-Auladell, Lara Vallverdú, Núria Fucui Santamaría, Paula Moral, Antonio Pérez, José Ignacio Li, Changda Fuste, Victoria Lerma, Enrique Corcoy, Rosa Pitoia, Fabián Escolà-Gil, Joan Carles Mato, Eugènia Low-Density Lipoprotein Receptor Is a Key Driver of Aggressiveness in Thyroid Tumor Cells |
title | Low-Density Lipoprotein Receptor Is a Key Driver of Aggressiveness in Thyroid Tumor Cells |
title_full | Low-Density Lipoprotein Receptor Is a Key Driver of Aggressiveness in Thyroid Tumor Cells |
title_fullStr | Low-Density Lipoprotein Receptor Is a Key Driver of Aggressiveness in Thyroid Tumor Cells |
title_full_unstemmed | Low-Density Lipoprotein Receptor Is a Key Driver of Aggressiveness in Thyroid Tumor Cells |
title_short | Low-Density Lipoprotein Receptor Is a Key Driver of Aggressiveness in Thyroid Tumor Cells |
title_sort | low-density lipoprotein receptor is a key driver of aggressiveness in thyroid tumor cells |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10342163/ https://www.ncbi.nlm.nih.gov/pubmed/37446330 http://dx.doi.org/10.3390/ijms241311153 |
work_keys_str_mv | AT revillagiovanna lowdensitylipoproteinreceptorisakeydriverofaggressivenessinthyroidtumorcells AT ruizauladelllara lowdensitylipoproteinreceptorisakeydriverofaggressivenessinthyroidtumorcells AT vallverdunuriafucui lowdensitylipoproteinreceptorisakeydriverofaggressivenessinthyroidtumorcells AT santamariapaula lowdensitylipoproteinreceptorisakeydriverofaggressivenessinthyroidtumorcells AT moralantonio lowdensitylipoproteinreceptorisakeydriverofaggressivenessinthyroidtumorcells AT perezjoseignacio lowdensitylipoproteinreceptorisakeydriverofaggressivenessinthyroidtumorcells AT lichangda lowdensitylipoproteinreceptorisakeydriverofaggressivenessinthyroidtumorcells AT fustevictoria lowdensitylipoproteinreceptorisakeydriverofaggressivenessinthyroidtumorcells AT lermaenrique lowdensitylipoproteinreceptorisakeydriverofaggressivenessinthyroidtumorcells AT corcoyrosa lowdensitylipoproteinreceptorisakeydriverofaggressivenessinthyroidtumorcells AT pitoiafabian lowdensitylipoproteinreceptorisakeydriverofaggressivenessinthyroidtumorcells AT escolagiljoancarles lowdensitylipoproteinreceptorisakeydriverofaggressivenessinthyroidtumorcells AT matoeugenia lowdensitylipoproteinreceptorisakeydriverofaggressivenessinthyroidtumorcells |